Starling Oncology, Inc. Revenue Breakdown
No Revenue Breakdown for DFPH on this site yet.
- 2025-12-31: Others Not split by product in the filing$502.73M100.00%; Total revenue $502.73M.
- 2024-12-31: Others Not split by product in the filing$393.41M100.00%; Total revenue $393.41M.
- 2023-12-31: Others Not split by product in the filing$324.24M100.00%; Total revenue $324.24M.
- 2022-12-31: Others Not split by product in the filing$252.48M100.00%; Total revenue $252.48M.
Source checked: the stored Revenue Breakdown page for DFPH.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $502.73M 100.00% | $502.73M |
| 2024-12-31 | Not split by product in the filing $393.41M 100.00% | $393.41M |
| 2023-12-31 | Not split by product in the filing $324.24M 100.00% | $324.24M |
| 2022-12-31 | Not split by product in the filing $252.48M 100.00% | $252.48M |
| 2021-12-31 | Not split by product in the filing $203.00M 100.00% | $203.00M |
| 2020-12-31 | Not split by product in the filing $187.51M 100.00% | $187.51M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $161.28M 100.00% | $161.28M |
| 2026-03-31 | Not split by product $147.44M 100.00% | $147.44M |
| 2025-12-31 | Not split by product $141.96M 100.00% | $141.96M |
| 2025-09-30 | Not split by product $136.56M 100.00% | $136.56M |
| 2025-06-30 | Not split by product $119.80M 100.00% | $119.80M |
| 2025-03-31 | Not split by product $104.41M 100.00% | $104.41M |
| 2024-12-31 | Not split by product $100.27M 100.00% | $100.27M |
| 2024-09-30 | Not split by product $99.90M 100.00% | $99.90M |
| 2024-06-30 | Not split by product $98.58M 100.00% | $98.58M |
| 2024-03-31 | Not split by product $94.67M 100.00% | $94.67M |
| 2023-12-31 | Not split by product $85.79M 100.00% | $85.79M |
| 2023-09-30 | Not split by product $82.03M 100.00% | $82.03M |
| 2023-06-30 | Not split by product $80.22M 100.00% | $80.22M |
| 2023-03-31 | Not split by product $76.19M 100.00% | $76.19M |
| 2022-12-31 | Not split by product $71.42M 100.00% | $71.42M |
| 2022-09-30 | Not split by product $64.98M 100.00% | $64.98M |
| 2022-06-30 | Not split by product $60.92M 100.00% | $60.92M |
| 2022-03-31 | Not split by product $55.16M 100.00% | $55.16M |
| 2021-12-31 | Not split by product $52.30M 100.00% | $52.30M |
| 2021-09-30 | Not split by product $52.27M 100.00% | $52.27M |
| 2021-06-30 | Not split by product $49.84M 100.00% | $49.84M |
| 2021-03-31 | Not split by product $48.58M 100.00% | $48.58M |